HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity
HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity
Recruiting · NCT07586215 · Registry updated 2026-09-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HER2-PET: Predicting T-DXd Efficacy and HER2 Heterogeneity | Breast Cancer Metastatic | Recruiting | Not stated | 2026-09-10 | NCT07586215 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan Cancer Hospital | Shanghai | China | 3 |